Drug intelligence / Profile preview

Cam-Plus

Development stage
Unknown
Lead developer
Cam Neuro Pharma
Modality
Small Molecules
Administration
Oral
01

Overview

Cam-Plus is a fixed-dose combination pharmaceutical product developed by CAM Neuro Pharma, containing 500mg of citicoline and 800mg of piracetam. It is primarily indicated for stroke rehabilitation, the treatment of brain trauma, and as a cognitive enhancer (nootropic) for cognitive impairment. Citicoline acts as a neuroprotective agent by serving as an intermediate in the synthesis of phosphatidylcholine, which is essential for the repair and structural integrity of neuronal membranes; it also enhances the production of acetylcholine. Piracetam is a cyclic derivative of gamma-aminobutyric acid (GABA) that functions as a nootropic by protecting the brain against hypoxia and modulating various ion channels on the nerve cell membrane to improve neurotransmission. Together, the components work to nourish nerve cells, protect them from oxidative or ischemic damage, and improve overall neuronal survival and function.

Brand names
Cam-Plus
Other names
Citicoline + Piracetam tabletsCiticoline and Piracetam combination
02

Targets

GluR (Glutamate receptors)

Beyond the preview

Go deeper on Cam-Plus.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cam-Plus.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call